title: Risk Malignancy Index (RMI) in patients with abnormal pelvic mass: Comparing RMI 1, 2 and 3 in an Australian population.
authors.affiliation: Department of Gynaecologic Oncology, Hunter New England Centre for Gynaecological Cancer, John Hunter Hospital, Newcastle, New South Wales, Australia. ganendraraj@hotmail.com
authors.forename: Ganendra Raj
authors.initials: GR
authors.lastname: Kader Ali Mohan
authors.forename: Kenneth
authors.initials: K
authors.lastname: Jaaback
authors.forename: Anthony
authors.initials: A
authors.lastname: Proietto
authors.forename: Randall
authors.initials: R
authors.lastname: Robertson
authors.forename: Donald
authors.initials: D
authors.lastname: Angstetra
mesh_terms: D000005:Abdomen / Q000000981:diagnostic imaging; D000328:Adult; D001315:Australia; D018394:CA-125 Antigen / Q000097:blood; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D010048:Ovarian Cysts / Q000175:diagnosis* / Q000000981:diagnostic imaging; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging; D012017:Referral and Consultation; D018570:Risk Assessment / Q000379:methods; D014218:Triage / Q000379:methods*; D014463:Ultrasonography
chemical_list: D018394:CA-125 Antigen